A61K 9/5084
Mixtures of one or more drugs in different galenical forms, at least
Official title: {Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs (tablets containing such a mixture A61K9/2077)}
A61K9/5084 (Mixtures of one or more drugs in different galenical forms, at least) appears on 880 US grants and 1,464 published applications in this corpus.
Search patents in A61K- Granted patents
- 880
- Published applications
- 1,464
- Assignees
- 575
- Inventors
- 2,126
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 3 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 4 | 0 |
| 1986 | 2 | 0 |
| 1987 | 2 | 0 |
| 1988 | 8 | 0 |
| 1989 | 6 | 0 |
| 1990 | 9 | 0 |
| 1991 | 3 | 0 |
| 1992 | 5 | 0 |
| 1993 | 11 | 0 |
| 1994 | 9 | 0 |
| 1995 | 10 | 0 |
| 1996 | 8 | 0 |
| 1997 | 7 | 0 |
| 1998 | 10 | 0 |
| 1999 | 15 | 0 |
| 2000 | 11 | 0 |
| 2001 | 22 | 9 |
| 2002 | 16 | 38 |
| 2003 | 41 | 86 |
| 2004 | 15 | 64 |
| 2005 | 15 | 60 |
| 2006 | 16 | 45 |
| 2007 | 13 | 69 |
| 2008 | 12 | 70 |
| 2009 | 11 | 75 |
| 2010 | 22 | 64 |
| 2011 | 18 | 76 |
| 2012 | 32 | 45 |
| 2013 | 37 | 62 |
| 2014 | 52 | 92 |
| 2015 | 56 | 79 |
| 2016 | 57 | 85 |
| 2017 | 51 | 71 |
| 2018 | 42 | 50 |
| 2019 | 42 | 80 |
| 2020 | 28 | 43 |
| 2021 | 38 | 38 |
| 2022 | 15 | 38 |
| 2023 | 26 | 35 |
| 2024 | 34 | 43 |
| 2025 | 27 | 26 |
| 2026 | 14 | 21 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics8 Sep 2026US 12,728,110 B2Flamel Ireland Limited
- Ion-exchange composition with water-soluble mucoadhesive polymers11 Aug 2026US 12,702,643 B2Fertin Pharma A/S
- Alkaline phosphatase formulations and uses thereof28 Jul 2026US 12,691,077 B2Theriva Biologics, Inc.
- Pharmaceutical compositions comprising nitroxoline lysinate, preparation method therefor and use thereof16 Jun 2026US 12,653,818 B2Asieris Pharmaceuticals (Shanghai) Co., Ltd.
- Modified release compositions of nafamostat and methods of using same26 May 2026US 12,636,253 B2Ensysce Biosciences Inc.
- Oral pharmaceutical compositions of dabigatran etexilate17 Sep 2026US 2026/0272904 A1Breckenridge Pharmaceutical, Inc.
- Pharmaceutical formulations comprising naltrexone and/or bupropion13 Aug 2026US 2026/0232599 A1Nalpropion Pharmaceuticals LLC
- Novel formulation for lacosamide6 Aug 2026US 2026/0224500 A1Shanghai Aucta Pharmaceuticals Co., Ltd.
- Methods of preparing multiphase statin and omega-3 fatty acid soft capsule formulations6 Aug 2026US 2026/0224501 A1Catalent Ontario Limited
- Drug loaded modified release pellets16 Jul 2026US 2026/0199253 A1ADD Advanced Drug Delivery Technologies Ltd.
Most cited
By later US patents
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions616US 6,569,463 B2Lipocine Inc. · 2003
- Extended release pharmaceutical formulations461US 5,133,974 AKV Pharmaceutical Company · 1992
- Drug delivery system and method of making the same385US 4,897,268 ASouthern Research Institute · 1990